How to buy eFFECTOR Therapeutics (EFTR) shares in the UK

Learn how to easily invest in eFFECTOR Therapeutics shares.

eFFECTOR Therapeutics Inc.
NASDAQ: EFTR - USD
BIOTECHNOLOGY
$13.01
+ $0.31 ( + 2.44%)

eFFECTOR Therapeutics Inc. (EFTR) is a leading biotechnology business based in the US. It opened the day at $19.69 after a previous close of $19.58. During the day the price has varied from a low of $18.2001 to a high of $20.38. The latest price was $19.3 (25 minute delay). eFFECTOR Therapeutics is listed on the NASDAQ. All prices are listed in US Dollars.

How to buy shares in eFFECTOR Therapeutics

  1. Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: EFTR in this case.
  5. Research eFFECTOR Therapeutics shares. The platform should provide the latest information available.
  6. Buy your eFFECTOR Therapeutics shares. It's that simple.
The whole process can take as little as 15 minutes.

eFFECTOR Therapeutics share price (NASDAQ:EFTR)

Use our graph to track the performance of EFTR stocks over time.

eFFECTOR Therapeutics shares at a glance

Information last updated 2021-09-17.
Open$19.69
High$20.38
Low$18.2001
Close$19.3
Previous close$19.58
Change$-0.28
Change %-1.43%
Volume480,963
Information last updated 2021-10-14.
52-week range$8.33 - $36.69
50-day moving average$15.6331
200-day moving average$11.2998
Dividend yieldN/A (0%)
Earnings per share (TTM)$-0.905
Promoted
eToro Free Stocks

Invest in eFFECTOR Therapeutics shares with 0% commission

Other fees apply. Your capital is at risk.

  • Unlimited trades, with no dealing charges or management fees
  • Pay no stamp duty on UK shares (saving 0.5%)
  • Create an account today in a few minutes
Capital at risk

Fees for buying 50x eFFECTOR Therapeutics shares with popular platforms

Both exchange rates and share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.

Platform Platform fee Min. initial deposit Trading fee estimate
Freetrade logo £0 No minimum £3.16
£705.20 total
Capital at risk
eToro Free Stocks logo £0 $50 £3.51
£705.55 total
Capital at risk
Fineco logo £0 No minimum £7.02
£709.06 total
Capital at risk
Degiro Share Dealing logo £0 £0.01 £1.27
£703.31 total
Capital at risk
Stake logo £0 £50 £3.66
£705.69 total
Capital at risk
Hargreaves Lansdown Fund and Share Account logo £0 £1 £19.12
£721.15 total
Capital at risk
interactive investor Trading Account logo £9.99 per month No minimum £18.67
£720.70 total
Capital at risk
Halifax Share Dealing Account logo £36 per year £20 £18.42
£720.46 total
Capital at risk

Full comparison of share dealing platforms

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Is it a good time to buy eFFECTOR Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

eFFECTOR Therapeutics price performance over time

Historical closes compared with the last close of $19.3

1 week (2021-10-08) 63.01%
1 month (2021-09-16) -1.43%
3 months (2021-07-15) 94.95%
6 months (2021-04-15) 93.97%

Financials

Revenue TTM $1.3 million
Gross profit TTM $20.2 million
Return on assets TTM 0%
Return on equity TTM 0%
Profit margin 0%
Market capitalisation $524.2 million

TTM: trailing 12 months

How to short and sell eFFECTOR Therapeutics shares

  1. Create a CFD or spread betting account.
  2. Search for the stock code. E.g. "EFTR.US"
  3. Choose your position size.
  4. Select "sell" rather than "buy".
  5. Confirm your position and keep tabs on it. You may wish to set limits on your position.

There are currently 119,460 eFFECTOR Therapeutics shares held short by investors – that's known as the "short interest". This figure is 60.4% down from 301,564 last month.

There are a few different ways that this level of interest in shorting eFFECTOR Therapeutics shares can be evaluated.

Short interest ratio (SIR)

eFFECTOR Therapeutics's "short interest ratio" (SIR) is the quantity of eFFECTOR Therapeutics shares currently shorted divided by the average quantity of eFFECTOR Therapeutics shares traded daily (recently around 4.0 million). eFFECTOR Therapeutics's SIR currently stands at 0.03. In other words for every 100,000 eFFECTOR Therapeutics shares traded daily on the market, roughly 30 shares are currently held short.

However eFFECTOR Therapeutics's short interest can also be evaluated against the total number of tradable eFFECTOR Therapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case eFFECTOR Therapeutics's short interest could be expressed as 0.0122% of the tradable shares (for every 100,000 tradable eFFECTOR Therapeutics shares, roughly 12 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against eFFECTOR Therapeutics.

Find out more about how you can short eFFECTOR Therapeutics stock.

eFFECTOR Therapeutics share dividends

We're not expecting eFFECTOR Therapeutics to pay a dividend over the next 12 months. Typically it's companies that have been around for longer that pay dividends (eFFECTOR Therapeutics had its IPO on 26 August 2021). However, you can browse other dividend-paying shares in our guide.

Win £500 to get your trading started

Subscribe to trending stock alerts for a chance to win

By submitting, you agree to the Finder Privacy and Cookies Policy and Terms of Use

Shares similar to eFFECTOR Therapeutics

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked
Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site